The group's principal activity is to provide biopharmaceutical and biotechnology research services. The group provides universities, hospitals, research organizations and entrepreneurs with a commercial development infrastructure for their technologies, including technology transfer licensing skills, regulatory expertise and assistance in obtaining funding for development. The group was founded in 1999. The group operates from the United States.
